Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 821,000 | 857,000 | 874,000 | 1,102,000 | 1,005,000 |
| Marketable Securities | 97,000 | 77,000 | 65,000 | N/A | N/A |
| Receivables | 215,000 | 212,000 | 208,000 | 215,000 | 175,000 |
| Inventories | 106,000 | 100,000 | 91,000 | 95,000 | 97,000 |
| Other current assets | 25,000 | 95,000 | 25,000 | 32,000 | 37,000 |
| TOTAL | $1,264,000 | $1,341,000 | $1,263,000 | $1,444,000 | $1,314,000 |
| Non-Current Assets | |||||
| PPE Net | 50,000 | 53,000 | 56,000 | 58,000 | 57,000 |
| Investments And Advances | 117,000 | 81,000 | 85,000 | 0 | 0 |
| Intangibles | 67,000 | 73,000 | 78,000 | 82,000 | 84,000 |
| Other Non-Current Assets | 173,000 | 172,000 | 242,000 | 248,000 | 245,000 |
| TOTAL | $407,000 | $379,000 | $461,000 | $388,000 | $386,000 |
| Total Assets | $1,671,000 | $1,720,000 | $1,724,000 | $1,832,000 | $1,700,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 633,000 | 684,000 | 643,000 | 720,000 | 550,000 |
| Other current liabilities | 82,000 | 87,000 | 63,000 | 66,000 | 136,000 |
| TOTAL | $744,000 | $787,000 | $728,000 | $804,000 | $712,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 237,000 | 237,000 | 238,000 | 239,000 | 239,000 |
| Other Non-Current Liabilities | 463,000 | 466,000 | 526,000 | 586,000 | 588,000 |
| TOTAL | $700,000 | $703,000 | $764,000 | $825,000 | $827,000 |
| Total Liabilities | $1,444,000 | $1,490,000 | $1,492,000 | $1,629,000 | $1,539,000 |
| Shareholders' Equity | |||||
| Common Shares | 69,000 | 70,000 | 71,000 | 70,000 | 72,000 |
| Retained earnings | 1,496,000 | 1,484,000 | 1,472,000 | 1,438,000 | 1,395,000 |
| Other shareholders' equity | -1,346,000 | -1,331,000 | -1,318,000 | -1,312,000 | -1,313,000 |
| TOTAL | $227,000 | $230,000 | $232,000 | $203,000 | $161,000 |
| Total Liabilities And Equity | $1,671,000 | $1,720,000 | $1,724,000 | $1,832,000 | $1,700,000 |